Brain organoids: A revolutionary tool for modeling neurological disorders and development of therapeutics
Biotechnology and Bioengineering · 2024-02 · 121 (2) · 489-506
DOI: 10.1002/bit.28606 ↗At a glance
Übersichtsarbeit in Biotechnology and Bioengineering, published online on 2023-11-28. Written by Prabha Acharya and 4 co-authors. Institution: Department of Biomedical Engineering, University of North Texas, Denton, Texas, USA. Major MEDLINE topics: Autism Spectrum Disorder, Induced Pluripotent Stem Cells, Nervous System Diseases, Zika Virus. Cited 51 times so far (Crossref); 131 references. The full text is freely available in PubMed Central. Funded by: NIDDK NIH HHS, NIEHS NIH HHS, NCATS NIH HHS.
Abstract (original language)
Brain organoids are self‐organized, three‐dimensional (3D) aggregates derived from pluripotent stem cells that have cell types and cellular architectures resembling those of the developing human brain. The current understanding of human brain developmental processes and neurological disorders has advanced significantly with the introduction of this in vitro model. Brain organoids serve as a translational link between two‐dimensional (2D) cultures and in vivo models which imitate the neural tube formation at the early and late stages and the differentiation of neuroepithelium with whole‐brain regionalization. In addition, the generation of region‐specific brain organoids made it possible to investigate the pathogenic and etiological aspects of acquired and inherited brain disease along with drug discovery and drug toxicity testing. In this review article, we first summarize an overview of the existing methods and platforms used for generating brain organoids and their limitations and then discuss the recent advancement in brain organoid technology. In addition, we discuss how brain organoids have been used to model aspects of neurodevelopmental and neurodegenerative diseases, including autism spectrum disorder (ASD), Rett syndrome, Zika virus‐related microcephaly, Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD).
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Biomedical Engineering, University of North Texas, Denton, Texas, USA.
- Department of Healthcare Information Technology, Inje University, Gimhae, Republic of Korea.
ORCID profiles: Sehoon Jeong
Funding
- NIDDK NIH HHS
- NIEHS NIH HHS
- NCATS NIH HHS
- NIH HHS
- National Research Foundation of Korea
- National Institutes of Health
Cite
APA
Acharya, P., Choi, N. Y., Shrestha, S., Jeong, S., & Lee, M. Y. (2024). Brain organoids: A revolutionary tool for modeling neurological disorders and development of therapeutics. Biotechnology and Bioengineering, 121(2), 489-506. https://doi.org/10.1002/bit.28606
Vancouver
Acharya P, Choi NY, Shrestha S, Jeong S, Lee MY. Brain organoids: A revolutionary tool for modeling neurological disorders and development of therapeutics. Biotechnology and Bioengineering. 2024;121(2):489-506. doi:10.1002/bit.28606
BibTeX
@article{Acharya2024,
author = {Acharya, Prabha and Choi, Na Young and Shrestha, Sunil and Jeong, Sehoon and Lee, Moo-Yeal},
title = {Brain organoids: A revolutionary tool for modeling neurological disorders and development of therapeutics},
journal = {Biotechnology and Bioengineering},
year = {2024},
volume = {121},
number = {2},
pages = {489--506},
doi = {10.1002/bit.28606}
}
EUVIMED